Analytical Data
-
基因名
FGF10
- Application
-
别名
FGF10;Fibroblast growth factor 10
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
O15520
-
表达区间
40-208aa
-
氨基酸序列
MLGQDMVSPEATNSSSSSFSSPSSAGRHVRSYNHLQGDVRWRKLFSFTKY FLKIEKNGKVSGTKKENCPYSILEITSVEIGVVAVKAINSNYYLAMNKKG KLYGSKEFNNDCKLKERIEENGYNTYASFNWQHNGRQMYVALNGKGAPRR GQKTRRKNTSAHFLPMVVHS
-
分子量
19 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Fibroblast growth factor 10 (FGF10) is a member of the fibroblast growth factor family, which plays a crucial role in various biological processes, including embryonic development, tissue repair, and the regulation of cell proliferation and differentiation. Research on FGF10 has garnered significant interest due to its involvement in the formation and maintenance of multiple organ systems, particularly the lungs, pancreas, and salivary glands. Disruptions in FGF10 signaling pathways have been implicated in a variety of pathologies, such as congenital disorders, cancer, and pulmonary diseases. The recombinant form of FGF10 has been explored for its therapeutic potential, especially in regenerative medicine and tissue engineering, where it may promote wound healing and enhance tissue regeneration through its angiogenic properties. Furthermore, studies have demonstrated that FGF10 can induce the proliferation of epithelial cells and the formation of new structures, making it a promising candidate for treating conditions related to tissue damage. By producing FGF10 as a recombinant protein, researchers aim to elucidate its biological functions and develop novel therapeutic strategies, thus advancing our understanding of its roles in both health and disease. Continuous investigations into the mechanisms of action and potential clinical applications of FGF10 hold the promise of significant breakthroughs in regenerative therapies and targeted treatment approaches.












